Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Sanofi and Amgen poised for cholesterol drug sales

Sanofi and Amgen poised for cholesterol drug sales BioMarin last year. .

Pharma deals in May 2015

Pharma deals in May 2015 Sanofi has been adept in this area with its previous access to a PRV for Alirocumab for dyslipidaemia (in partnership with Regeneron who had originally purchased the PRV from Biomarin) for

Sanofi pays $245m for FDA priority review voucher

Sanofi pays $245m for FDA priority review voucher It is not the first time has shelled out to accelerate development of one of its products, having paid $67.5m to BioMarin last year for a PRV that allowed its

Alexion boosts rare disease portfolio with $8.4bn Synageva buy

Alexion boosts rare disease portfolio with $8.4bn Synageva buy Meanwhile, Horizon Pharma stumped up $1.1bn for urea cycle disorder specialist Hyperion Therapeutics and BioMarin bought Prosensa for $840m, gaining access to its muscular dystrophy drug drisapersen. .

Monthly dosing effective for Sanofi's alirocumab

Monthly dosing effective for Sanofi's alirocumab Despite Amgen's first-to-file status, Sanofi and Regeneron have sought to shorten their rival's lead by purchasing an FDA priority review voucher originally awarded to BioMarin Pharmaceutical for

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics